Vanderbilt Clinical Oncology Research Career Development Award

项目总结 范德比尔特临床肿瘤学研究职业发展计划(VCORCDP)为初级教师提供 用设计和实施的工具和经验进行以患者为中心的癌症研究 假说驱动的研究，并有效地领导癌症研究项目。这一计划是 范德比尔特英格拉姆癌症中心(VICC)，其活动嵌入了整个VICC企业， 培训与癌症相关的各个专业的顶尖研究人员。这一计划确保我们开发出一种 强大和多样化的新兴调查人员渠道，他们拥有必要的技能来推动有影响力的 计划，并通过多学科和社区参与加速了他们的发展轨迹 集中学习。VCORCDP的主要组成部分是肿瘤学的临床指导研究 有针对性的教学培训，可能会导致临床研究或其他批准的理科硕士学位 个性化的教育途径和团队技能发展，暴露于癌症的广度 研究。我们的导师是由39名忠于职守、经验丰富的教职员工组成的多元化团队。学者们进行研究 在以下三个领域之一的癌症护理连续体系中：1)临床试验和药物开发，2) 翻译癌症生物学，以及3)癌症健康结果和流行病学。通过定期会议 与项目主任、同行学者和指导委员会一起，以及准备个人 发展计划和结构化的进展报告，VCORCDP学者为他们的职业发展量身定做 能够解决各自领域中最相关和最有意义的问题。该项目由两个人共同领导 内科科学家，进行转译研究的内科肿瘤学家和 从事人口科学和临床研究。代表多样性的内部咨询委员会 VCORCDP研究的一部分对个别学者的进展和项目的成功进行评估。量度 包括计划参与者多样性、计划完成率、留住以研究为重点的职业、资助 成功、出版和影响。外部咨询委员会，由一名癌症流行病学家、一名 社区代表和四名肿瘤内科医生兼科学家为 计划，确保满足国家劳动力需求和癌症优先事项，并监测进展情况， 成就，以及进一步推进方案的轨迹。已有56名学者进入 VCORCDP自成立以来，57%为男性，43%为女性。截至2021年6月，有7名学者(12%)代表 乌里姆集团。到目前为止，我们的56名学者在他们的职业生涯中已经发表了1800多篇手稿。在50个国家中 毕业的学者中，45人(90%)继续从事研究密集型职业，45人中有38人(84%) 同行评审的赠款支持，包括临床试验。VCORCDP将继续取得成功 培养研究人员，领导以患者为中心的癌症研究，推进癌症护理。

PROJECT SUMMARY The Vanderbilt Clinical Oncology Research Career Development Program (VCORCDP) provides junior faculty conducting patient-oriented research in cancer with the tools and experience to design and implement hypothesis-driven research and effectively lead cancer research projects. This program is a cornerstone of the Vanderbilt Ingram Cancer Center (VICC), and its activities are embedded across the entire VICC enterprise, training leading investigators from every specialty related to cancer. This program ensures that we develop a strong and diverse pipeline of emerging investigators who have the skills necessary to drive impactful programs, and who have been accelerated in their trajectory by multidisciplinary and community-engaged focused learning. The primary components of VCORCDP are mentored clinical research in oncology coupled with tailored didactic training that may lead to a Master of Science in Clinical Investigation or other approved individualized educational pathway and group skill development, with exposure to the breadth of cancer research. Our mentors are a diverse group of 39 committed, experienced faculty. Scholars conduct research across the cancer care continuum in one of three domains: 1) Clinical Trials and Drug Development, 2) Translational Cancer Biology, and 3) Cancer Health Outcomes and Epidemiology. Through regular meetings with the Program Directors, peer scholars, and mentorship committees, as well as preparation of Individual Development Plans and structured Progress Reports, VCORCDP scholars tailor their career development to be able to address the most relevant and meaningful issues in their field. The program is co-led by two physician scientists, a medical oncologist who conducts translational research and a pediatric oncologist who conducts population science and clinical research. An Internal Advisory Committee representing the diversity of VCORCDP research evaluates the progress of individual scholars and the program’s success. Metrics include diversity of program participants, program completion, retention in research-focused careers, funding success, publication, and impact. An External Advisory Committee, composed of a cancer epidemiologist, a community representative, and four oncology physician-scientists, provides input into the scientific direction of program, ensures it is meeting national workforce needs and cancer priorities, and monitors progress, accomplishments, and trajectory to further programmatic advancement. Fifty-six scholars have entered the VCORCDP since its inception, 57% male and 43% female. As of June 2021, seven scholars (12%) represent URiM groups. Our 56 scholars have published over 1,800 manuscripts over their careers to date. Of the 50 scholars who have graduated, 45 (90%) continue in research-intensive careers, and 38 of the 45 (84%) have peer-reviewed grant support, including clinical trials. The VCORCDP is poised to continue to successfully develop investigators to lead patient-oriented cancer research and advance cancer care.